Drug intelligence / Profile preview

tripterygium wilfordii polyglycoside + vitamin d3

Development stage: Unknown
Lead developer: Gynogen
Modality: Small Molecules
Administration: Oral

Overview

A combination drug containing Tripterygium wilfordii polyglycoside (glycosides) and Vitamin D3 (cholecalciferol). Tripterygium wilfordii polyglycoside is an extract from the thunder god vine plant with anti-inflammatory and immunomodulatory properties. Vitamin D3 supports calcium absorption, bone health, and immune function. This combination is used to treat various inflammatory and autoimmune conditions, particularly rheumatic immune diseases, kidney disorders, and potentially uterine fibroids.

Brand names: F-IBROIDS
Other names: tripterygium wilfordii glycosides + vitamin d3lei gong teng + cholecalciferol

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on tripterygium wilfordii polyglycoside + vitamin d3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on tripterygium wilfordii polyglycoside + vitamin d3.

Explore the full profile